A Open-label, Single-dose Study to Investigate The Pharmacokinetics Between a GL2907 XL and Oxycontin CR Tab. 10mg in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Healthy
Interventions
DRUG

Oxycodone

Oxycodone XL 20mg(20mg once a day, fasted)

DRUG

Oxycodone

Oxycodone XL 20mg/day(20mg once a day, after high fat meal)

DRUG

Oxycodone

Oxycodone 20mg/day (10mg twice a day, fasted)

Trial Locations (1)

Unknown

AJOU University Hospital, Suwon

Sponsors
All Listed Sponsors
lead

GL Pharm Tech Corporation

INDUSTRY